UBS Group’s Revolution Healthcare Acquisition Corp. SAIL Warrant. REVHW Stock Holding History

UBS Group’s Portfolio REVHW Stock Details REVHW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,474	Closed	–	–	11765
2022 Q3	$0	Buy	6,474 +42	+0.7%	+$6	﹤0.01%	11562
2022 Q2	$2K	Sell	6,432 -5,349	-45%	-$1.79K	﹤0.01%	9753
2022 Q1	$5K	Buy	11,781 +10,465	+795%	+$5.63K	﹤0.01%	9241
2021 Q4	$1K	Sell	1,316 -1,570	-54%	-$1.32K	﹤0.01%	10158
2021 Q3	$3K	Buy	+2,886	New	+$3.29K	﹤0.01%	8896

Other funds holding REVHW

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

UBS Group's REVHW Position: Q4 2022 in Review

UBS Group sold out of Revolution Healthcare Acquisition Corp. SAIL Warrant. (REVHW) in Q4 2022, closing a stake of 6,474 shares.

UBS Group first reported a position in REVHW in Q3 2021 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 1 fund tracked by Wall St. Rank holds REVHW as of Q4 2022.

UBS Group reported no remaining Revolution Healthcare Acquisition Corp. SAIL Warrant. position as of Q4 2022 after selling out during the quarter.
UBS Group sold 6,474 Revolution Healthcare Acquisition Corp. SAIL Warrant. shares in Q4 2022.
UBS Group first reported a position in Revolution Healthcare Acquisition Corp. SAIL Warrant. in Q3 2021 and held it in 5 quarters.
UBS Group's Revolution Healthcare Acquisition Corp. SAIL Warrant. position peaked at $5K in Q1 2022.
1 fund tracked by Wall St. Rank held Revolution Healthcare Acquisition Corp. SAIL Warrant. as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.